Selamectin: a novel broad-spectrum endectocide for dogs and cats.

Vet Parasitol

Animal Health Discovery, Central Research Division, Pfizer Limited, Sandwich, Kent, UK.

Published: August 2000

Selamectin, 25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22, 23-dihydro-5-(hydroxyimino)-avermectin B1 monosaccharide, is a novel endectocide with a unique combination of efficacy and safety in dogs and cats following both oral and topical administration. The compound is active against fleas and ticks, intestinal hookworms and ascarids, and immature heartworms. Also it is well tolerated at higher dosages than 22,23-dihydroavermectin B1a (DHAVM) or milbemycin oxime in Collies, which is a breed known to exhibit idiosyncratic sensitivity to avermectins.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-4017(00)00289-2DOI Listing

Publication Analysis

Top Keywords

dogs cats
8
selamectin novel
4
novel broad-spectrum
4
broad-spectrum endectocide
4
endectocide dogs
4
cats selamectin
4
selamectin 25-cyclohexyl-25-de1-methylpropyl-5-deoxy-22
4
25-cyclohexyl-25-de1-methylpropyl-5-deoxy-22 23-dihydro-5-hydroxyimino-avermectin
4
23-dihydro-5-hydroxyimino-avermectin monosaccharide
4
monosaccharide novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!